MCCC2

methylcrotonyl-CoA carboxylase subunit 2, the group of Methylcrotonyl-CoA carboxylase subunits

Basic information

Region (hg38): 5:71579531-71658706

Links

ENSG00000131844NCBI:64087OMIM:609014HGNC:6937Uniprot:Q9HCC0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 3-methylcrotonyl-CoA carboxylase deficiency (Supportive), mode of inheritance: AR
  • 3-methylcrotonyl-CoA carboxylase deficiency (Definitive), mode of inheritance: AR
  • 3-methylcrotonyl-CoA carboxylase 2 deficiency (Definitive), mode of inheritance: AR
  • 3-methylcrotonyl-CoA carboxylase 2 deficiency (Strong), mode of inheritance: AR
  • 3-methylcrotonyl-CoA carboxylase 2 deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
3-Methylcrotonyl-CoA carboxylase 2 deficiencyARBiochemicalTherapy may not be necessary/effective in some individuals, but medical (eg, carnitine, glycine) and dietary (eg, low protein, leucine restricted) therapy may be beneficial in some individuals; Precautions in the setting of stressors such as viral illnesses may be beneficialBiochemical; Neurologic7128647; 1293382; 8598650; 8831079; 9544913; 11181649; 11170888; 15877210; 16835865; 17968484; 22030835; 22264772; 22642865; 25356967

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MCCC2 gene.

  • 3-methylcrotonyl-CoA carboxylase 2 deficiency (40 variants)
  • not provided (7 variants)
  • Methylcrotonyl-CoA carboxylase deficiency (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCCC2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
145
clinvar
3
clinvar
150
missense
5
clinvar
37
clinvar
146
clinvar
3
clinvar
191
nonsense
13
clinvar
22
clinvar
1
clinvar
36
start loss
0
frameshift
22
clinvar
15
clinvar
2
clinvar
39
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
33
clinvar
37
splice region
2
14
31
2
49
non coding
1
clinvar
37
clinvar
111
clinvar
56
clinvar
205
Total 44 108 188 260 59

Highest pathogenic variant AF is 0.0000197

Variants in MCCC2

This is a list of pathogenic ClinVar variants found in the MCCC2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-71587090-A-T Benign (Jun 19, 2018)684211
5-71587123-C-G Benign (Jun 19, 2018)684213
5-71587242-G-A Likely benign (Apr 09, 2019)1213286
5-71587309-A-G 3-methylcrotonyl-CoA carboxylase 2 deficiency Benign (Jun 19, 2021)1175310
5-71587388-G-A 3-methylcrotonyl-CoA carboxylase 2 deficiency • not specified Conflicting classifications of pathogenicity (Jan 13, 2018)354100
5-71587406-C-G not specified Likely benign (Jul 05, 2017)378120
5-71587428-GTGGGCCGTCCTGAGGTTAGCCCTGCGGCCGTGTGCCCGCGCCTCTCCCGCCGGGCCGCGCGCCTA-G 3-methylcrotonyl-CoA carboxylase 2 deficiency Pathogenic (Aug 23, 2023)2871586
5-71587431-G-C Uncertain significance (Jan 21, 2014)167275
5-71587434-C-A 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Feb 10, 2023)3002053
5-71587438-C-T 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Nov 25, 2023)1084854
5-71587450-C-T 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Jun 22, 2022)1638292
5-71587457-C-T Uncertain significance (Jun 01, 2016)809764
5-71587463-C-G 3-methylcrotonyl-CoA carboxylase 2 deficiency Uncertain significance (May 13, 2022)2125069
5-71587470-C-T 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Mar 24, 2023)2008340
5-71587476-C-G 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Nov 20, 2023)1564261
5-71587479-C-G not specified • 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Feb 19, 2020)513584
5-71587479-C-T 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Mar 08, 2022)2093501
5-71587482-G-C 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Nov 29, 2022)2097021
5-71587483-C-T 3-methylcrotonyl-CoA carboxylase 2 deficiency • Inborn genetic diseases Uncertain significance (Jan 20, 2023)905569
5-71587485-G-C 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely benign (Jul 01, 2022)2012950
5-71587486-C-T Inborn genetic diseases Uncertain significance (Jun 23, 2023)2606004
5-71587493-A-C 3-methylcrotonyl-CoA carboxylase 2 deficiency • Inborn genetic diseases Conflicting classifications of pathogenicity (May 08, 2023)2150106
5-71587493-A-G 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely pathogenic (Jan 29, 2024)2711697
5-71587493-AT-A 3-methylcrotonyl-CoA carboxylase 2 deficiency Pathogenic (May 28, 2023)2868871
5-71587494-TC-T 3-methylcrotonyl-CoA carboxylase 2 deficiency Likely pathogenic (Feb 20, 2023)2676494

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MCCC2protein_codingprotein_codingENST00000340941 1771417
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.51e-110.9371256740741257480.000294
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3062983130.9510.00001643640
Missense in Polyphen122137.710.885911633
Synonymous0.03021121120.9960.000006071097
Loss of Function2.042235.00.6280.00000199409

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007240.000724
Ashkenazi Jewish0.000.00
East Asian0.0005980.000544
Finnish0.0001850.000185
European (Non-Finnish)0.0002370.000237
Middle Eastern0.0005980.000544
South Asian0.0004900.000490
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3- methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism. {ECO:0000269|PubMed:17360195}.;
Disease
DISEASE: 3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]: An autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3- hydroxyisovaleric acid and 3-methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency. {ECO:0000269|PubMed:11170888, ECO:0000269|PubMed:11181649, ECO:0000269|PubMed:11406611, ECO:0000269|PubMed:16010683, ECO:0000269|PubMed:17968484, ECO:0000269|PubMed:21071250, ECO:0000269|PubMed:22150417, ECO:0000269|PubMed:22264772, ECO:0000269|PubMed:22642865, ECO:0000269|PubMed:25382614, ECO:0000269|PubMed:27601257}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Biotin transport and metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;leucine degradation;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Valine, leucine and isoleucine degradation;Valine Leucine Isoleucine degradation (Consensus)

Recessive Scores

pRec
0.180

Intolerance Scores

loftool
0.206
rvis_EVS
-0.22
rvis_percentile_EVS
37.43

Haploinsufficiency Scores

pHI
0.0357
hipred
N
hipred_score
0.237
ghis
0.501

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.977

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mccc2
Phenotype

Gene ontology

Biological process
leucine catabolic process;biotin metabolic process;coenzyme A metabolic process;protein heterooligomerization
Cellular component
3-methylcrotonyl-CoA carboxylase complex, mitochondrial;mitochondrion;mitochondrial matrix;cytosol;methylcrotonoyl-CoA carboxylase complex
Molecular function
methylcrotonoyl-CoA carboxylase activity;protein binding;ATP binding